CLBS—>LSTA (Lisata Therapeutics) at tomorrow’s open, pursuant to previously announced reverse-merger: https://www.globenewswire.com/news-release/2022/09/14/2515879/18623/en/Caladrius-Biosciences-Announces-Approval-of-Merger-and-Name-Change-to-Lisata-Therapeutics.html